Annelies Verbiest

6PUBLICATIONS
42CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 22, 2026
Real-world utilization of pembrolizumab dosing schedules in Belgium: a multi-center retrospective study using a common data model and natural language processing.

|Apr 20, 2026
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma.

|Apr 02, 2026
Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.

Alexey Ryzhenkov, Salma Rachidi, Valtteri Nieminen

|Mar 18, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.

Matthias Vanderkerken, Koen Van Eygen, Veerle Galle

|Apr 03, 2021
MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma.

Lisa Kinget, Eduard Roussel, Diether Lambrechts

|Sep 11, 2020
MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.

Annelies Verbiest, Vincent Van Hoef, Cristina Rodriguez-Antona

Pageof 1

Frequent Collaborators

2 joint publications

Lisa Kinget

1 joint publications

Matthias Vanderkerken

1 joint publications

Koen Van Eygen

1 joint publications

Kristof Theys